Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Imm...
Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Immunotherapy Committee of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
About this item
Full title
Author / Creator
Publisher
Singapore: Codon Publications
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Codon Publications
Subjects
More information
Scope and Contents
Contents
Although currently approved to treat severe asthma and chronic spontaneous urticaria, omalizumab has also been an effective and safe add-on treatment for other allergic diseases. Namely, omalizumab has been proposed to be used as add-on therapy in patients with allergic rhinitis and asthma and undergoing specific allergen immunotherapy (AIT). AIT i...
Alternative Titles
Full title
Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Immunotherapy Committee of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2732535789
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2732535789
Other Identifiers
ISSN
0301-0546
E-ISSN
1578-1267,0301-0546
DOI
10.15586/aei.v50i6.495
